Bildkälla: Stockfoto

ISR Holding: Signs an agreement with Gerresheimer - Redeye

Redeye is encouraged to learn that ISR has signed an agreement with Gerresheimer for clinical-scale production of the nasal inhaler IcoOne for ISR’s nasally inhaled dry powder COVID-19 vaccine.

Redeye is encouraged to learn that ISR has signed an agreement with Gerresheimer for clinical-scale production of the nasal inhaler IcoOne for ISR’s nasally inhaled dry powder COVID-19 vaccine.
Börsvärldens nyhetsbrev
ANNONSER